Company intelligence / Profile preview
Sinovac Life Sciences
Beijing, Beijing, Chinasinovac.com ↗
- Ownership
- Private
- Employees
- ~3000
- Development stage
- Other
01
Overview
Sinovac Life Sciences is a major global developer and manufacturer of vaccines for infectious diseases. It is most recognized for the development and mass production of CoronaVac, an inactivated COVID-19 vaccine that received WHO Emergency Use Listing. The company maintains a robust commercial portfolio including vaccines for Hepatitis A (Healive), Enterovirus 71 (Inlive), and various influenza strains.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccine
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Butantan InstituteBio FarmaSino BiopharmaceuticalVaxCell Bio
Beyond the preview
Go deeper on Sinovac Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinovac Life Sciences.